Top compounds associated with response to MYEOV


Feature Type Standardized
Nominal ANOVA
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.11 0.03
mRNA IPR-456 CTRPv2 pan-cancer AAC -0.087 0.03
mRNA methylstat CTRPv2 pan-cancer AAC -0.094 0.03
mRNA AS605240 GDSC1000 pan-cancer AAC 0.075 0.03
mRNA dabrafenib GDSC1000 pan-cancer AAC 0.068 0.03
mRNA parbendazole CTRPv2 pan-cancer AAC -0.07 0.03
mRNA CCT007093 GDSC1000 pan-cancer AAC -0.078 0.03
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.03
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.03
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.08 0.03
Download CSV